Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023

BioNewsCast Press Release Distribution Service

Statins: The World Market, 2009-2024

Liver Cancer Drug Pipeline Update 2008

Bioinformatics Markets

New Products

Live Cell & Kinetic HCS Imaging Trends 2008

2008 Trends to Watch: Healthcare Technology

2009 Trends to Watch: Healthcare Technology

Biosimilars Series: Stakeholder Analysis

Biotech M&A Strategies: Deal assessments, trends and future prospects

Building a Network of Networks to Achieve Interoperability in Healthcare (Strategic Focus)

Business Trends - Healthcare Technology (Customer Focus)

Claims Processing for Healthcare Payers (Market Model)

Clinical Decision Support in Healthcare - One step closer to the Omniscient Clinician (Strategic Focus)

Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential

BioPortfolio | Pharmalicensing Reports

Early Stage and Discovery Deals Strategy Structure and Payment Terms 2nd Edition
Today early-stage partnering is a core component of both biotech and pharmaceutical business strategy, allowing companies to access promising new and emerging compounds and technologies. To become a successful player within the life science industry it is crucial to understand the changing dynamics of the industry’s early stage deal-making trends.

The China Pharmaceutical Market A Strategic Opportunity Analysis 2007
China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around $US12 billion.

Business Opportunities in China: The impact of the WTO
Business Opportunities in China: The impact of the WTO

Key points covered in this report:

> The development of the Chinese pharmaceutical industry and its current status

> Changes in the industry on China's accession to the WTO

> The competitiveness of the Chinese pharmaceutical industry in the international market

> The R&D and business opportunities for pharmaceutical firms considering alliances in China

> Significant points for consideration for companies looking to capture business opportunities in China.

Legal aspects of outsourcing contracts in the pharmaceutical industry: A practical guide
Paul Ranson's comprehensive report covers the contractual features of the outsourcing process from start to finish. This report includes information on the legal aspects of outsourcing services at all stages of product development, manufacturing and exploitation, including preclinical and clinical research, manufacture, logistics and sales.

The Licensing Agreement in Pharmaceutical Business Development (3rd Edition)
Pharmalicensing's best selling licensing report has returned, fully revised and updated with new statistics, data and expert advice.

Licensing is at it's peak - in-licensed products now generate over 30% of the revenues of the major pharmaceutical companies and some 25% of the ‘blockbusters’ of recent years have a history of cross-company licensing, that's why it's more important than ever to understand and secure the right deal and terms. This report examines the key factors that must be considered when drawing up a suitable contract, and includes highlights and tips for negotiating and understanding complex license agreements.

Partneringdesk Deals and Alliances therapy report
Partneringdesk™ Deals and Alliances therapy reports provide a comprehensive summary of the deals and alliances announced in the therapeutic area in the last five years, in a clear and accessible printable format.

Every deal entry includes financial information where disclosed, such as headline values and upfront payments.

Partneringdesk Deals Briefings
Partneringdesk™ Deals Briefings

Dealmaking activity of 50 of the top pharmaceutical companies

Partneringdesk™ Deals Briefings provide a comprehensive summary of the deals and alliances announced by fifty of the top pharmaceutical and biotechnology companies in the last five years, in a clear and accessible printable format.

Partneringweek
Weekly deals, alliance and financing intelligence direct to your desktop

Partneringweek™ is an interactive spreadsheet containing the week's deals, alliances and financing announcements from the worldwide biopharma sector. Each issue of Partneringweek includes over 80 deals and alliances announcements, and over 20 financing announcements.

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions